Transcription of Madopar (levodopa) Data Sheet (DS) - Medsafe
{{id}} {{{paragraph}}}
Example: biology
Madopar (levodopa) Data Sheet (DS) - Medsafe
Madopar 160202 1 Data Sheet Madopar levodopa + benserazide Capsules , 125 and 250; dispersible tablet ; HBS modified-release capsule 125 Description Composition Active ingredient Madopar is a combination of levodopa and the decarboxylase inhibitor benserazide (as hydrochloride) in a ratio of 4:1. The preparation is available as capsules of three different strengths, as single scored dispersible tablets of one strength and as capsules with a controlled release action of one strength. Excipients Madopar , 125 and 250 capsules All three forms of the capsules contain microcrystalline cellulose, talc, povidone, magnesium stearate, gelatin, and the colourant(s) indigo carmine, titanium dioxide and iron oxide (red, yellow or black).
MADOPAR 160202 1 Data Sheet MADOPAR® Levodopa + benserazide Capsules 62.5, 125 and 250; dispersible tablet 62.5; HBS modified-release capsule 125
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
120 MG DISPERSIBLE TABLETS, Dispersible, 120 MG DISPERSIBLE TABLETS Artemether and lumefantrine, Sasol Germany GmbHSasol Germany GmbH, Fluox DS, FLUOX, REVISION OF MONOGRAPH ON TABLETS, World, DISPERSIBLE ASPIRIN 75MG TABLETS BP, Fao specifications and evaluations for, Use of currently available fixed-dose combination